NewsMarkets

Business

Rogaine Sales Surge 30% as GLP-1 Weight Loss Drugs Boost Hair Growth Demand

The hair-loss remedy sees a 30% sales increase this year due to side effects from popular weight-loss medications.

2 publishers · 2 articles · first seen 5 Nov 2026 · updated 11d ago

Headline and summary written by an AI model from the linked articles; not reviewed by a person. How this was made

This story has stopped developing; this page is its permanent record. More from that day

The story so far

2 publishers have covered this in 2 articles since 5 Nov 2026. Bloomberg.com published first, on 5 November at 15:30 UTC; Quartz followed 26 min later. The most recent article, from Quartz, appeared on 5 November at 15:57 UTC.

Outlets reporting it: Bloomberg.com (major outlet), Quartz.

No prediction market is linked to this story at the moment. We match each story to Polymarket and Kalshi markets by what they ask, and show one only when it is close enough to be useful; if a market on this topic opens, it will appear here. Meanwhile, browse every market we track or see how stories and markets are matched.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Rogaine Rides GLP-1 Wave With 30% Sales Surge This Year Bloomberg.com ·
  2. Rogaine sales are rising. It might be thanks to weight loss drugs Quartz

In this story

  • Rogaine
  • Ozempic
Embed this story

Paste this into any web page to show the live odds, with a link back here.